Immunogenicity of the BNT162b2 vaccine in frail or disabled nursing home residents: COVID-A study. Salmeron Rios S, Mas Romero M, Cortes Zamora EB, Tabernero Sahuquillo MT, et al. J Am Geriatr Soc 2021;69:1441-1447.

Read + Share

Amedeo Smart

Independent Medical Education

Salmeron Rios S, Mas Romero M, Cortes Zamora EB, Tabernero Sahuquillo MT, et al. Immunogenicity of the BNT162b2 vaccine in frail or disabled nursing home residents: COVID-A study. J Am Geriatr Soc 2021;69:1441-1447.
PMID: 33768521